Low dose actinomycin D preferentially activates p53-p21 pathway in aerodigestive tract cancers: Implication for cyclotherapy

被引：0
|
作者：
Adeluola, Adeoluwa A. [1 ]
Amin, A. R. M. Ruhul [1 ]
机构：
[1] Marshall Univ, Huntington, WV USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1837
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells
    Gonnella, Roberta
    Yadav, Shivangi
    Gilardini Montani, Maria Saveria
    Granato, Marisa
    Santarelli, Roberta
    Garufi, Alessia
    D'Orazi, Gabriella
    Faggioni, Alberto
    Cirone, Mara
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 327 - 335
  • [42] Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
    Zenz, Thorsten
    Haebe, Sonja
    Denzel, Tina
    Mohr, Julia
    Winkler, Dirk
    Buehler, Andreas
    Sarno, Antonio
    Groner, Silja
    Mertens, Daniel
    Busch, Raymonde
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD, 2009, 114 (13) : 2589 - 2597
  • [43] Actinomycin D synergistically enhances the efficacy of CDDP by activating P53-PUMA pathway via downregulating P53-MDM2 complex on KB cells
    WANG Lin
    PANG Xiao-cong
    XU Huan-li
    YANG Sheng-qian
    YU Zi-ru
    DU Guan-hua
    中国药理学与毒理学杂志, 2016, (10) : 1071 - 1072
  • [44] Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM/p21 pathway
    Li, Si-Jie
    Liang, Xin-Yue
    Li, Hai-Jun
    Yang, Guo-Zi
    Li, Wei
    Li, Zhuo
    Zhou, Lei
    Wen, Xue
    Yu, De-Hai
    Cui, Jiu-Wei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (01) : 548 - 554
  • [45] NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells (vol 12, 112, 2021)
    Xu, Yun
    Nasri, Masoud
    Dannenmann, Benjamin
    Mir, Perihan
    Zahabi, Azadeh
    Welte, Karl
    Morishima, Tatsuya
    Skokowa, Julia
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [46] Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D
    Krzesniak, Malgorzata
    Zajkowicz, Artur
    Matuszczyk, Iwona
    Rusin, Marek
    MECHANISMS OF AGEING AND DEVELOPMENT, 2014, 139 : 11 - 21
  • [47] Cyclic mechanical tension reinforces DNA damage and activates the p53-p21-Rb pathway to induce premature senescence of nucleus pulposus cells
    Feng, Chencheng
    Yang, Minghui
    Zhang, Yang
    Lan, Minghong
    Huang, Bo
    Liu, Huan
    Zhou, Yue
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (06) : 3316 - 3326
  • [48] Low dose of wortmannin reduces radiosensitivity of human glioblastoma cells through the p53 pathway
    Okaichi, K
    Suzuki, K
    Morita, N
    Ikeda, M
    Takahashi, H
    Matsuda, N
    Watanabe, M
    Okumura, Y
    ONCOLOGY REPORTS, 2002, 9 (04) : 859 - 862
  • [49] 5-aza-2′-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation
    Zhu, WG
    Hileman, T
    Ke, Y
    Wang, PC
    Lu, SL
    Duan, WR
    Dai, ZY
    Tong, TJ
    Villalona-Calero, MA
    Plass, C
    Otterson, GA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) : 15161 - 15166
  • [50] Low-dose Actinomycin-D treatment re-establishes the tumour-suppressive function of P53 in RELA-positive ependymoma
    Tzaridis, Theophilos
    Milde, Till
    Pajtler, Kristian W.
    Bender, Sebastian
    Jones, David T. W.
    Mueller, Simone
    Wittmann, Andrea
    Schlotter, Magdalena
    Kulozik, Andreas E.
    Lichter, Peter
    Collins, V. Peter
    Witt, Olaf
    Kool, Marcel
    Korshunov, Andrey
    Pfister, Stefan M.
    Witt, Hendrik
    ONCOTARGET, 2016, 7 (38) : 61860 - 61873
12345